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Macrophages are necessary in multiple processes during the immune response or
inflammation. This review emphasizes the critical role of the mitogen-activated protein
kinases (MAPKs) and mitogen kinase phosphatase-1 (MKP-1) in the functional activities
of macrophages. While the phosphorylation of MAPKs is required for macrophage
activation or proliferation, MKP-1 dephosphorylates these kinases, thus playing a
balancing role in the control of macrophage behavior. MKP-1 is a nuclear-localized
dual-specificity phosphatase whose expression is regulated at multiple levels, including
at the transcriptional and post-transcriptional level. The regulatory role of MKP-1 in
the interplay between MAPK phosphorylation/dephosphorylation makes this molecule
a critical regulator of macrophage biology and inflammation.
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MACROPHAGES A KEY ELEMENT OF THE IMMUNE SYSTEM
Monocytes are the precursors of macrophages and they originate from undifferentiated stem cells
in the bone marrow. Differentiation is induced in response to growth factors such as M-CSF, IL-3,
and GM-CSF. M-CSF being the only specific one because the M-CSF receptor (CSF1R, M-CSF-R,
or CD115 is encoded by the c-fms proto-oncogene) is present only in the monocyte/macrophage
lineage. Monocytes reach all the tissues in the body via the blood and then they become
macrophages (Epelman et al., 2014). In response to various factors, including cytokines, cell-cell
contacts, and extracellular matrix interactions, macrophages differentiate to more specialized cells,
depending on the tissue. For example, in response to RANKL, these cells differentiate to osteoclasts
in the bone (Edwards andMundy, 2011), to Kupffer cells in the liver, to Langerhans cells in the skin,
to bone marrow macrophages in the bone, and to crypt macrophages in the intestine. The activities
of differentiated macrophages vary in function of the tissue. The interaction of macrophages with
factors such as GM-CSF, IL-4, and TGF-β induces differentiation to dendritic cells. These cells are
key elements in antigen presentation in the lymph node a process that induces T cell activation
and the acquired immune response. The immune system responds to stress induced by chemical,
physical, and infectious agents by producing inflammation. In this process, macrophages play a
key role, initially through their capacity to remove bacteria or parasites. This activity is achieved
through many components that can indirectly damage the surrounding tissues. After this pro-
inflammatory activity (classical activation or M1), macrophages remove all the damaged tissues
and start the reconstruction process. In this anti-inflammatory phase (alternative activation orM2),
macrophages prompt the synthesis of the extracellular matrix and cell growth (Dey et al., 2014).
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Under physiological conditions, monocytes show the Ly6C−
and CD43++ phenotype in mice and CD14− and CD16++
phenotype in humans (Ziegler-Heitbrock et al., 2010). Localized
around blood vessels, these cells serve to monitor healthy tissues.
When homeostasis is altered, they enter the affected tissues to
initiate an early immune response. During the first 24 h of this
response, the inflammatory loci are invaded first by neutrophils
and then by monocytes carrying the Ly6C++ CD43− phenotype
in mice and the CD14++ CD16− phenotype in humans. These
monocytes trigger the pro- and anti-inflammatory activities
mentioned earlier. The same macrophages that are polarized to
pro-inflammatory action become anti-inflammatory a few days
later (Arnold et al., 2007; Takeuch and Akira, 2011). Interestingly,
pro-inflammatory activity by agents such IFN-γ or LPS block
macrophage proliferation (Xaus et al., 1999). However, during
anti-inflammatory activation, tissue macrophages proliferate
locally (Arnold et al., 2007) in a processmediated by IL-4 (Jenkins
et al., 2011).
MAPKs AND MACROPHAGE BIOLOGY
MAPKs have been conserved over evolution; however, the
subcellular compartmentalization and the kinetics of MAPK
activation are cell-type specific, and these kinases orchestrate
a range of cellular responses. One of the critical issues in
macrophage biology, as in most cell types, is their capacity to
respond to stimuli and to proliferate. Although M-CSF, GM-
CSF, and IL-3 induce macrophage proliferation, M-CSF is the
only specific grow factor for these cells. M-CSF interacts with its
receptor-specific receptor CSF1R on the cell surface and induces
the activation of signal transduction. The interaction is followed
by receptor dimerization, which leads to the autophosphorylation
of tyrosine residues in the intracellular domain and the
recruitment of signaling molecules (Yu et al., 2012). Macrophage
proliferation required the stimulation of the MAPK signaling
pathway (Pixley and Stanley, 2004). These serine/threonine
kinases are induced by external signals, and they play a critical
role in regulating the growth, activation, differentiation, and
apoptosis of various types of cells. MAPK activation calls for
phosphorylation on the threonine and tyrosine residues situated
in the activation loop. Upon phosphorylation, these kinases
regulate transcription factors such as Ets-1, Elk/TCF, and AP-
1, all of which are involved in immediate, early and late gene
expression (Yoon and Seger, 2006), and also in protein expression
by regulating the stability, transport or translocation of mRNA
species that contain AU-rich elements (Wang and Liu, 2007). In
response to growth factors, ERK-1/2, c-Jun NH2-terminal kinase
1 (JNK-1), and p38 are activated in macrophages. However, for
the proliferation of these cells, only ERK-1/2 phosphorylation
is required (Jaworowski et al., 1999; Valledor et al., 2000a;
Sanchez-Tillo et al., 2007). The activation/phosphorylation of
Ras is necessary to phosphorylate ERK-1/2 and the downstream
targets such as the ribosomal S6 kinases and mitogen- and
stress-activated kinases 1 and 2 (Murphy and Blenis, 2006).
Activated ERK-1/2 translocate to the nucleus and, by means
of phosphorylation, activate a number of transcription factors
that regulate genes involved in proliferation. Remarkably,
M-CSF triggers other pathways independent of MAPKs to
induce macrophage survival through the phosphorylation of
phosphoinositide 3-kinase which prompts the translocation and
activation of Akt (Comalada et al., 2004).
Lipopolysaccharide (LPS) is a powerful inflammatory signal
present in the membrane of Gram-negative bacteria. It regulates
the expression of many genes, including TNF-α, which causes
septic shock when present in large amounts. ERK-1/2 becomes
phosphorylated through the interaction of LPS with LPS binding
protein (a serum protein), CD14, and TLR4 (membrane proteins
in macrophages; Valledor et al., 2000b). The inhibition of this
phosphorylation blocks the production of TNF-α and IL-1β. This
observation serves to demonstrate the role of these twomolecules
in macrophage activation (Valledor et al., 2000a).
IFN-γ, a major endogenous macrophage activator, not only
requires Stat1 for signaling but also MAPKs. At early times
(30 min), p38 is activated strongly, but ERK-1/2 and JNK-
1 become phosphorylated between 2 and 5 h. Although
p38 and ERK-1/2 regulate the expression of genes of the
innate response, such as chemokines, TNF-α, and inducible
NO synthase, the genes involved in antigen presentation are
regulated by JNK-1 (Valledor et al., 2008b). These results
emphasize the diversity of MAPK kinetics and activity in
macrophages.
The kinetics of MAPK phosphorylation with respect to the
proliferation or functional activation of macrophages may be
associated with various factors, such as cell-surface receptor
concentration and the different pathways used after ligand-
receptor engagement (Murphy and Blenis, 2006). The induction
of ERK-1/2 phosphorylation by M-CSF or LPS involves the same
molecules, namely Ras, Raf, and MEK 1/2 (Casals-Casas et al.,
2009). However, the early steps differ. While M-CSF receptor
encloses a tyrosine kinase domain in the intra-cytoplasmic
region, thus inducing rapid phosphorylation, LPS interacts with
LPS-binding protein CD14, and finally TLR4 and requires more
time to initiate the phosphorylation (Kolch, 2005).
THE MKP-1 PHOSPHATASE AND ITS
REGULATION
MKP-1 phosphatase, also called dual specificity phosphatase 1
(DUSP1), is expressed ubiquitously. However, it is regulated in
a cell-context manner and is able to dephosphorylate tyrosine
or serine/threonine residues. MKPs dephosphorylate and
consequently inactivate ERK-1/2 (Pouyssegur and Lenormand,
2003), p38, MAPKs (Kaiser et al., 2004), and JNKs (Sanchez-
Perez et al., 1998). At least 11 MKP family members of these dual
phosphatases have been found to differ in cellular specificity,
subcellular localization, and substrate specificity (Farooq and
Zhou, 2004).
MKP-1 is composed of two domains, one is bound the
MAPK in the NH2-terminus and the other is the dual-
specificity phosphatase domain located in the COOH terminus
(Camps et al., 2000). This phosphatase localizes exclusively
to the nucleus through a NH2-terminus LXXLL motif (Wu
Frontiers in Molecular Biosciences | www.frontiersin.org 2 June 2016 | Volume 3 | Article 28
Lloberas et al. Macrophages and Mitogen Kinase Phosphatase 1
et al., 2005). The catalytic activity is regulated through
interaction with MAPKs mediated by a kinase interaction motif
(Doddareddy et al., 2012).
In most cases, the induction of phosphatases is a negative
response mechanism of the kinases that triggers the expression
or activation of the phosphatases. In macrophages, MPK-1
induction yields conflicting results. In primary cultures of bone
marrow-derived macrophages, LPS-induced MKP-1 expression
is partially blocked by co-administration of inhibitors of ERK-
1/2 and p38 (Ananieva et al., 2008) or when macrophage from a
p38 KO mouse are used (Kim et al., 2008). In other studies using
the same cell type, the inhibition of the MEK pathway required
for M-CSF- or LPS-induced ERK-1/2 phosphorylation was not
found to affect MKP-1 expression, thereby showing that this
expression is independent of kinase activation (Valledor et al.,
1999, 2000b).
The early steps in signal transduction to induce MKP-1
involves the phosphorylation of PKCε (Valledor et al., 1999,
2000b). Interestingly, the expression of MKP-1 induced by
either M-CSF or LPS also requires Raf-1 activation, as does the
phosphorylation of ERK-1/2 (Sanchez-Tillo et al., 2006). Another
mediator of MKP-1 stimulation is JNK-1, and inactivation of
this kinase results in prolonged ERK phosphorylation (Sanchez-
Tillo et al., 2007). Finally, inhibition of mTOR induces MKP-1
expression, thereby suggesting that the repression of immunity is
mediated through MKP-1 (Rastogi et al., 2013).
MKP-1 is not expressed under basal conditions; however, in
response to various stimuli MKP-1 is an immediate early gene
that requires transcriptional activation, although its regulation is
also mediated at several other levels. In the MKP-1 promoter,
a region containing a CREB/AP-1 box is essential for the
induction of transcription through a variety of different stimuli
(Arthur et al., 2004; Ananieva et al., 2008; Cho et al., 2008;
Kim et al., 2008; Casals-Casas et al., 2009). Upon activation
by M-CSF or LPS, this box is occupied by phosphorylated
CREB and c-Jun. It has been reported that the phosphorylation
of CREB is mediated by p38 (Kamata et al., 2005) and by
ERK-1/2. However, this phosphorylation is not direct but
mediated through MSK1/2 activated by either ERK-1/2 or p38
(Ananieva et al., 2008; Kim et al., 2008). However, it has been
reported that the inhibition of ERK does not block MKP-1
induction by M-CSF and LPS (Valledor et al., 1999, 2000b).
Other studies have described that CREB phosphorylation is
mediated by M-CSF-induced PI-3K (Kanagasundaram et al.,
1999) or by LPS-activated PKA (Zhong et al., 1997). Vitamin
D induces MKP-1, thus inhibiting pro-inflammatory cytokine
production, and the binding of the vitamin D receptor at
the vitamin D response element in the MKP-1 promoter is
increased (Zhang et al., 2012). In the context of the proliferation
vs. activation issue, IFN-γ, the major endogenous activator
of macrophages, inhibits M-CSF-induced MKP-1 expression
(Valledor et al., 2008a). The inhibition is mediated through
STAT1, but no such repressive activity has been reported for this
transcription factor. Transcription, in turn, calls for epigenetic
modifications or chromatin remodeling on the MKP-1 promoter
region. Through phosphorylation and acetylation of histone H3,
chromatin is modified, thereby increasing the binding of RNA
polymerase II and inducing MKP-1 transcription (Li et al., 2001;
Figure 1).
MKP-1 mRNA in macrophages has a very short half-life
(Valledor et al., 1999). In other cellular models, the short mRNA
half-life has been related to AU-rich 3′ untranslated regions and
the RNA binding proteins HuR and NF90 (Kuwano et al., 2008).
It seems that NF90 represses the translation of mRNAs bearing
the AU-rich signature sequence without affecting their half-lives
(Kuwano et al., 2010). Tristetraprolin binds to these AU-rich
sequences of MKP-1 and thus forms part of a negative feedback
loop to limit the mRNA half-life (Emmons et al., 2008). In
fact, tristetraprolin expression is suppressed by MKP-1 through
inhibition of p38 (Huotari et al., 2012).
The activity of MKP-1 can be modified by stabilization
of his on protein, which is determined by its ERK-mediated
phosphorylation through a degradation pathway independent of
polyubiquitination (Crowell et al., 2014). If Ser359 and Ser364
become phosphorylated, the protein is stabilized (Brondello et al.,
1999); however, if phosphorylation occurs in Ser298 and Ser323,
then proteosomal degradation is facilitated (Lin et al., 2003).
We should mention that glucocorticoids not only induce the
transcription of MKP-1 but also attenuate their proteasomal
degradation (Kassel et al., 2001; Figure 1).
Metabolic stress in monocytes and macrophages induces
Nox4, an inducible NADPH oxidase that promotes MKP-
1-S-glutathionylation, resulting in MKP1 inactivation and
subsequent proteasomal degradation (Kim et al., 2012). This
observation shows that a redox-regulated mechanism links
oxidative stress directly to metabolic disorders and macrophage
hyperactivity.
The repressive cytokines IL-10 and TGF-β block most
immune responses and increase LPS-dependent MKP-1
induction, thereby enhancing the degree and duration of the
phosphatase and consequently dephosphorylating MAPKs with
the consequent inhibition of inflammatory cytokine production
(Jono et al., 2003; Hammer et al., 2005). Micro-RNA-101
(miR-101) and miR-210 transfections reduce LPS-dependent
induction of MKP-1 and also prolong the phosphorylation of
p38 and JNK (Zhu et al., 2010; Jin et al., 2014).
Glucocorticoids are one of the major families of inhibitors of
the immune response used in clinical practice. Remarkably, these
drugs increase the expression and decrease the degradation of
MKP-1. Consequently, MKP-1 dephosphorylates MAPKs, thus
decreasing the activity of these kinases, as well as reducing
macrophage activation (Kassel et al., 2001; Shipp et al., 2010).
However, the observation that MKP-1 KO mice with enhanced
cytokine expression remain sensitive to glucocorticoids suggests
that the drug targets molecules other than MKP-1 (Maier et al.,
2007; Wang et al., 2008).
In response to LPS, MKP-1 is acetylated by p300/CBP on
lysine 57 within its substrate-binding domain, thus increasing its
interaction and dephosphorylation of p38 (Cao et al., 2008). This
observation reveals another level of regulation of the functional
activity mediated by histone deacetylase isoforms (HDAC1,
HDAC2, and HDAC3; Jeong et al., 2014).
Therefore, the mechanisms regulating MKP-1 expression are
critical in determining the duration of MAPK phosphorylation
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FIGURE 1 | The regulation of MKP-1 arises by multiple mechanisms, including transcription, mRNA stability, and protein acetylation and degradation.
This last depends of different sites of phosphorylation.
and the length of the immune response (Manetsch et al., 2012;
Tomida et al., 2015).
THE SWITCH BETWEEN PROLIFERATION
AND ACTIVATION IS MEDIATED BY MKP-1
The activation and proliferation of macrophages are reciprocally
exclusive processes (Xaus et al., 1999); however, both require
ERK-1/2 phosphorylation, although with distinct kinetics.
For macrophage proliferation, ERK-1/2 phosphorylation
occurs with a prompt peak around 5 min, while for
activation the phosphorylation takes place later, around 15
min (Valledor et al., 2000a; Suzu et al., 2007; Figure 2).
The time course of ERK-1/2 dephosphorylation differs for
growth factors and activating molecules, occurring 30 min
after phosphorylation for M-CSF-induced proliferation
and 90 min for LPS-induced functional activation. MAPK
phosphorylation is regulated by the dominant action of
protein phosphatases, as evidenced by phosphorylation
being reversible even in the continued presence of activating
stimuli.
Both stimuli triggering proliferation and functional activation
induce nuclear MKP-1 (Valledor et al., 1999, 2000b). The
transcription of MKP-1 follows the same kinetics by M-CSF or
LPS, producing early or late mRNA, depending on the stimuli.
Regardless of whether macrophages are treated with M-CSF or
LPS, ERK-1/2 dephosphorylation is associated only with the
induction of MKP-1 (Valledor et al., 2008a; Figure 2). This
induction requires the binding and phosphorylation of CREB and
c-Jun, and the kinetics of these two molecules correlates to the
different times courses ofMKP-1 expression. The distinct kinetics
of dephosphorylation suggests that the critical factor that allows
LPS or IFN-γ to inhibit macrophage proliferation is related to the
duration of ERK phosphorylation. This hypothesis was tested by
inhibiting MKP-1 expression. However, Mkp-1 knockout (KO)
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FIGURE 2 | Interplay between MAPKs and MKP-1. (A) The kinetics of
MKP-1 induction determines the different time courses of ERK phosphorylation
governing the proliferation or the functional activation of macrophages. The
repression of MKP-1 expression prolongs ERK-1/2 phosphorylation and
blocks proliferation (Valledor et al., 1999, 2000a,b, 2008a; Xaus et al., 2001;
Sanchez-Tillo et al., 2007). (B) For balanced activation MKP-1 is required. The
absence of MKP-1 induces an excess of activation.
mice cannot be used for this purpose because compensatory
mechanisms replace the role of MKP-1 in proliferation. In
fact, in contrast to wild-type cells in which MKP-4 is not
induced by M-CSF, in MKP-1 deficient macrophages, there is
an early MKP-4 response to M-CSF. By using siRNA, it was
observed that the inhibition of MKP-1 expression extends ERK-
1/2 phosphorylation and blocks M-CSF-dependent proliferation
(Valledor et al., 2008a).
The inhibition of proliferation induced by IFN-γ stimulation
correlates with extended ERK-1/2 phosphorylation induced by
M-CSF and is due to the inhibition of MKP-1 expression
(Valledor et al., 2008a). Interestingly, this inhibition is mediated
by STAT1. This observation would suggest that this transcription
factor represses some genes.
TheM-CSF-dependent induction of MKP-1 expression can be
altered by other agents. MKP-1 expression can be inhibited by
signaling through extracellular matrix proteins, such as decorin
and fibrinogen (Xaus et al., 2001). As result of such inhibition,
ERK phosphorylation is extended, and macrophage proliferation
is inhibited (Figure 2).
OTHER ACTIVITIES REGULATED BY
MKP-1
MKP-1 KO mice show extended MAPK phosphorylation that
correlates with an increased expression of cytokines such as
TNF-α, IL-6, and IL-12, all of which increase inflammation
(mice exhibit kidney failure, severe hypotension, inflammatory
infiltrates in the lung and other tissues, and impaired circulation
compared with wild-type mice) and cause higher susceptibility
to endotoxic shock (Chi et al., 2006; Hammer et al., 2006,
2010; Salojin et al., 2006; Zhao et al., 2006; Frazier et al.,
2009; Rodriguez et al., 2010). In a microarray of 14,000 genes
from mkp-1−/− mouse spleen cells, 608 genes were found to
be upregulated (Hammer et al., 2006). The absence of MKP-
1 produces the longest p38 phosphorylation, which in turn
increases C/EBPβ phosphorylation, a critical process in several
LPS-induced genes (Serrat et al., 2014). Another mechanism to
by which to increase the gene expression of natural immunity
in the absence of MKP-1 may be related to histones such as H3,
which is a substrate of MKP-1 (Kinney et al., 2009). The loss of
histone dephosphorylation may affect the transcription of several
genes.
Interestingly, the half-lives of mRNAs of several cytokines,
including IL-6, IL-10, and TNF-α, seem to be controlled by
MKP-1 through translocation of RNA binding proteins from
the nucleus to the cytosol (Yu et al., 2011). Recent data shows
that MKP-1 modulates the activity of the cytokine mRNA by
destabilizing the phosphorylation status of tristetraprolin, an
RNA-destabilizing protein (Smallie et al., 2015).
In conclusion, in this review we have addressed the critical
issue of the duration of ERK-1/2 kinase phosphorylation
and its role in mediating macrophage proliferation or
functional activation. The duration of the phosphorylation
state is determined by the induction of MKP-1, thus
making MKP-1 one of the critical regulators of macrophage
biology.
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